Digital medical platform shares surged over 100% as drivers emerge

• Doximity reported Q1 revenue of $156.6 million and adjusted EBITDA of $74.8 million, both above consensus, and raised full-year revenue guidance by $6 million to $671-681 million
• CEO stated AI search brings in 10x revenue versus costs, with expectations that AI costs will decrease over time as models become more efficient
• Analysts note the AI search profit potential is likely not included in current guidance, and the stock rally triggered a short squeeze affecting the 17% short interest position

Market Summary: Doximity Shares Surge on AI Search Profitability

Key Developments

Doximity (DOCS) shares more than doubled in premarket trading Friday following revelations about exceptional AI search profitability. The digital medical platform's stock surge was amplified by a short squeeze, with approximately 17% of shares having been sold short.

Financial Performance

• Q1 FY2027 Results: Revenue reached $156.6 million with adjusted EBITDA of $74.8 million, both exceeding consensus estimates
• Full-Year Guidance: Raised by $6 million (5%) to a range of $671-$681 million
• AI Search Economics: CEO Jeffrey Tangney disclosed the product generates 10 times more revenue than operational costs

AI Search Impact

Management emphasized that AI costs are expected to decrease as models become more efficient, strengthening unit economics. The CEO noted the technology is expanding the company's total addressable market within healthcare and pharmaceutical sectors beyond initial expectations.

Analyst Perspectives

Analysts believe the raised guidance is conservative and doesn't fully incorporate AI search revenue potential. Piper Sandler's Jessica Tassan indicated the FY2027 raise "mostly comprised of the F1Q27 beat" and doesn't reflect significant contributions from the expanding AI commercial pipeline. Leerink Partnerships' Michael Cherney expressed confidence that AI investments will support attractive long-term margins.

Market Implications

The dramatic price movement represents both fundamental strength and technical factors. The short squeeze penalized bearish investors who bet against the company. The AI search profitability disclosure suggests potential for sustained margin expansion and market share growth in the digital healthcare platform sector.